HRIBF(HRIBF)
HRIBF
$162.47—Stale · unknown old
OTC • Last print unknown ago
$162.47—Stale · unknown old
No analyst ratings available
No analyst price targets available for HRIBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $388.07B | $431.27B | $456.91B | $454.84B | $472.73B |
| Low | $380.88B | $420.70B | $447.01B | $444.98B | $462.48B |
| High | $395.27B | $442.66B | $467.28B | $465.16B | $483.46B |
| EBITDA Avg | $88.33B | $105.27B | $115.70B | $120.42B | $126.26B |
| Low | $86.29B | $102.80B | $112.98B | $117.61B | $123.31B |
| High | $90.46B | $107.85B | $118.54B | $123.37B | $129.35B |
| EBIT Avg | $73.09B | $88.43B | $97.30B | $100.80B | $105.47B |
| Low | $71.05B | $85.96B | $94.58B | $97.99B | $102.52B |
| High | $75.22B | $91.01B | $100.15B | $103.75B | $108.56B |
| Net Income Avg | $51.89B | $62.91B | $69.28B | $71.79B | $75.15B |
| Low | $50.43B | $61.14B | $67.33B | $69.77B | $73.03B |
| High | $53.42B | $64.76B | $71.32B | $73.91B | $77.36B |
| EPS Avg | $1230.15 | $1491.32 | $1642.34 | $1701.97 | $1781.44 |
| Low | $1195.48 | $1449.30 | $1596.07 | $1654.01 | $1731.25 |
| High | $1266.44 | $1535.32 | $1690.80 | $1752.18 | $1834.01 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 3 / 1 | 3 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $94.38B | $116.67B | $97.77B | $105.33B | $108.86B | $129.02B |
| Low | $92.44B | $116.13B | $96.62B | $104.09B | $107.57B | $127.50B |
| High | $95.76B | $117.12B | $98.61B | $106.24B | $109.80B | $130.13B |
| EBITDA Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| Net Income Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| EPS Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 3 / — | 1 / — | 1 / — | 1 / — | 1 / — |